PATHWAY OPTIONS
There are a number of choices. Please ensure you select the correct pathway for your sample. Please give as much detail as possible for all samples.
Pathway 9A: Aplastic anaemia diagnosis (marrow)
Use for primary diagnosis of aplastic anaemia. Cytogenetics and molecular testing will be held, and may be performed depending on initial evaluation. Also send: peripheral blood sample to Leeds HMDS for flow cytometry PNH screening
The following tests will be performed:
- Morphology
- Flow cytometry (exclude acute leuakaemia)
- Trephine
- Cytogenetics (analyse as appropriate)
- Molecular (DNA analyse if indicated)
- RNA store sample
Pathway 9B: Aplastic anaemia follow up (marrow)
Use for aplastic anaemia follow up (select options at time of HODS request). Also send: peripheral blood sample to Leeds HMDS for Flow cytometry PNH screening
The following tests will be performed:
- Morphology
- Flow cytometry (optional, required only if concern about transformation)
- Trephine
- Cytogenetics (hold)
- Molecular DNA for myeloid gene panel